Sökresultat - Sadayoshi Ito

Förfina resultatet
  1. 1
    Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics.

    Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. av Sadayoshi Ito, Yufeng Ren

    Publicerad 1993
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  2. 2
    Pulse Pressure Amplification, Arterial Stiffness, and Peripheral Wave Reflection Determine Pulsatile Flow Waveform of the Femoral Artery

    Pulse Pressure Amplification, Arterial Stiffness, and Peripheral Wave Reflection Determine Pulsatile Flow Waveform of the Femoral Artery av Junichiro Hashimoto, Sadayoshi Ito

    Publicerad 2010
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Aortic Stiffness Determines Diastolic Blood Flow Reversal in the Descending Thoracic Aorta

    Aortic Stiffness Determines Diastolic Blood Flow Reversal in the Descending Thoracic Aorta av Junichiro Hashimoto, Sadayoshi Ito

    Publicerad 2013
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    Central Pulse Pressure and Aortic Stiffness Determine Renal Hemodynamics

    Central Pulse Pressure and Aortic Stiffness Determine Renal Hemodynamics av Junichiro Hashimoto, Sadayoshi Ito

    Publicerad 2011
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    An in vitro approach to the study of macula densa-mediated glomerular hemodynamics

    An in vitro approach to the study of macula densa-mediated glomerular hemodynamics av Sadayoshi Ito, Oscar A. Carretero

    Publicerad 1990
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    Role of the macula densa in renin release.

    Role of the macula densa in renin release. av Sadayoshi Ito, Oscar A. Carretero

    Publicerad 1985
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.

    Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. av Naoshi Ueda, K Kuno, Sadayoshi Ito

    Publicerad 1990
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Possible role of adenosine in the macula densa mechanism of renin release in rabbits.

    Possible role of adenosine in the macula densa mechanism of renin release in rabbits. av Sadayoshi Ito, Oscar A. Carretero, Robert Murray

    Publicerad 1985
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole.

    Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. av Sadayoshi Ito, Cynthia S. Johnson, Oscar A. Carretero

    Publicerad 1991
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk

    Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk av Sadayoshi Ito, Tasuku Nagasawa, Michiaki Abe, Takefumi Mori

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  11. 11
    Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study

    Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study av Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, Yasuyuki Okuda, Satoru Yamakawa

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria

    Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria av Sadayoshi Ito, Kenichi Shikata, Masaomi Nangaku, Yasuyuki Okuda, Tomoko Sawanobori

    Publicerad 2019
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study

    Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label... av Hiroshi Itoh, Sadayoshi Ito, Hiromi Rakugi, Yasuyuki Okuda, Satoshi Nishioka

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension

    Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension av Hiromi Rakugi, Sadayoshi Ito, Hiroshi Itoh, Yasuyuki Okuda, Satoru Yamakawa

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction

    Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction av Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, Yasuyuki Okuda, Setsuko Iijima

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide.

    Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide. av Luis A. Juncos, James H. Garvin, Oscar A. Carretero, Sadayoshi Ito

    Publicerad 1995
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy

    Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy av Susumu Ogawa, Takefumi Mori, Kazuhiro Nako, T. KATO, Kazuhisa Takeuchi, Sadayoshi Ito

    Publicerad 2006
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome

    The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome av Miho Senda, Susumu Ogawa, Kazuhiro Nako, Masashi Okamura, Takuya Sakamoto, Sadayoshi Ito

    Publicerad 2012
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial

    A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial av Masaaki Nakayama, Hideki Nakano, Hiromi Hamada, Noritomo Itami, Ryoichi Nakazawa, Sadayoshi Ito

    Publicerad 2010
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)

    Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study) av Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, Yasuyuki Okuda, M. Yoshimura, Satoru Yamakawa

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: